FDA approves PrEP drug. Lenacapavir is a twice-yearly HIV prevention shot more effective than daily pills.
Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future cure.
The administration canceled grants for research on LGBTQ health issues, claiming it did "nothing to enhance the health of many Americans."
The CDC issues national guidelines for use of Doxy-PEP to prevent STIs, amidst alarming rise in infection rates.